Skip to main content

Arcus Biosciences, Inc.

RCUSNYSE
$24.74+0.30 (+1.23% today)
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Arcus Biosciences, Inc. price and activity chart data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+70.9%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
Gilead Sciences, Inc.24.74%$969M58.76%Not reported
BlackRock, Inc.12.93%$506M0.01%Not reported
State Street Corp4.75%$186M0.01%Not reported
Wellington Management Group LLP4.64%$182M0.03%Reduce 3.19%
Montanova Capital, LLC3.76%$147M2.69%Reduce 5.06%
Vanguard Portfolio Management LLC3.52%$138M0.01%Not reported
FMR LLC3.19%$125M0.01%Not reported
Vanguard Capital Management LLC3.06%$120M0.00%Not reported
Citadel Advisors LLC2.47%$96.7M0.01%Not reported
Woodline Partners LP2.37%$92.7M0.29%Not reported
Geode Capital Management, LLC1.93%$75.5M0.00%Not reported
Siren, L.L.C.1.91%$74.6M1.51%Reduce 19.51%
Fisher Asset Management, LLC1.68%$66M0.02%Reduce 2.33%
Marshall Wace, LLP1.53%$60M0.05%Not reported
Samlyn Capital, LLC1.22%$47.7M0.78%Reduce 18.93%
Dimensional Fund Advisors LP1.13%$44.2M0.01%Not reported
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1.12%$43.8M0.04%Reduce 14.21%
Goldman Sachs Group Inc1.09%$42.8M0.00%Not reported
Soleus Capital Management, L.P.0.92%$36M1.24%Not reported
Sofinnova Investments, Inc.0.74%$29.2M1.51%Add 2.45%
Charles Schwab Investment Management Inc0.74%$29M0.00%Not reported
Northern Trust Corp0.73%$28.7M0.00%Not reported
Parkman Healthcare Partners LLC0.72%$28.3M2.90%Reduce 23.86%
Invesco Ltd.0.67%$26.1M0.00%Not reported
Baker Bros. Advisors LP0.67%$26M0.13%Add 103.27%
Bank of America Corp0.66%$25.8M0.00%Not reported
Morgan Stanley0.63%$24.5M0.00%Not reported
Aberdeen Group plc0.51%$20.1M0.03%Reduce 15.47%
Logos Global Management LP0.51%$20M0.86%Reduce 45.83%
Two Sigma Investments, LP0.50%$19.6M0.01%Not reported
Vanguard Fiduciary Trust Co0.49%$19M0.00%Not reported
T. Rowe Price Investment Management, Inc.0.46%$18.2M0.01%New Not reported
Bank of New York Mellon Corp0.43%$16.7M0.00%Not reported
Jacobs Levy Equity Management, Inc0.40%$15.8M0.06%Not reported
Ikarian Capital, LLC0.40%$15.6M1.68%New Not reported
Decheng Capital LLC0.37%$14.3M1.96%Reduce 2.73%
DAFNA Capital Management LLC0.35%$13.6M2.60%Reduce 0.45%
Principal Financial Group Inc0.33%$13.1M0.01%Not reported
JPMorgan Chase & Co0.33%$13.1M0.00%Not reported
Nomura Asset Management International Inc.0.30%$11.7M0.02%Not reported
UBS Group AG0.29%$11.4M0.00%Not reported
Patient Square Capital LP0.28%$11M1.70%Add 82.46%
PDT Partners, LLC0.25%$9.98M0.52%Reduce 16.68%
Public Sector Pension Investment Board0.23%$9.19M0.02%Reduce 1.70%
First Trust Advisors LP0.21%$8.37M0.00%Add 1972.33%
Nuveen, LLC0.18%$7.22M0.00%Not reported
Diadema Partners LP0.18%$6.9M0.87%Reduce 6.02%
Rhumbline Advisers0.17%$6.76M0.01%Not reported
Ensign Peak Advisors, Inc0.17%$6.65M0.01%Reduce 14.75%
Legal & General Group Plc0.15%$5.91M0.00%Not reported
50 of 215 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.